What is Rigel Pharmaceuticals's net investment in lease?

Rigel Pharmaceuticals (RIGL) reported net investment in lease of $785K in Q1 2026.

How has Rigel Pharmaceuticals's net investment in lease changed year-over-year?

Rigel Pharmaceuticals's net investment in lease decreased by 39.8% year-over-year, from $1.31M to $785K.

What is the long-term trend for Rigel Pharmaceuticals's net investment in lease?

Over 5 years (2020 to 2025), Rigel Pharmaceuticals's net investment in lease has grown at a -44.8% compound annual growth rate (CAGR), from $17.9M to $920K.

Rigel Pharmaceuticals RIGL Net Investment in Lease

Net Investment in Lease at other companies

Agios PharmaceuticalsAGIO

——

Nuvation BioNUVB

——

RegenxbioRGNX

——

Zevra Therapeutics, Inc.ZVRA

——

Eton Pharmaceuticals, Inc.ETON

——

Theravance BiopharmaTBPH

——

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's net investment in lease?: Rigel Pharmaceuticals (RIGL) reported net investment in lease of $785K in Q1 2026.
How has Rigel Pharmaceuticals's net investment in lease changed year-over-year?: Rigel Pharmaceuticals's net investment in lease decreased by 39.8% year-over-year, from $1.31M to $785K.
What is the long-term trend for Rigel Pharmaceuticals's net investment in lease?: Over 5 years (2020 to 2025), Rigel Pharmaceuticals's net investment in lease has grown at a -44.8% compound annual growth rate (CAGR), from $17.9M to $920K.